ScholarIQanswers from OpenAlex & ORCID
Todd M. Morgan
ResearcherPublications, citations & collaboration network
Todd M. Morgan is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Todd M. Morgan have?
ScholarIQindexed works
Todd M. Morgan has 739 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Todd M. Morgan have?
ScholarIQcitation count
Todd M. Morgan has 18,934 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Todd M. Morgan?
ScholarIQh-index
Todd M. Morgan has an h-index of 73 in OpenAlex.
What is the i10-index of Todd M. Morgan?
ScholarIQi10-index
Todd M. Morgan has an i10-index of 260 in OpenAlex.
What is the ORCID of Todd M. Morgan?
ScholarIQorcid
The ORCID for Todd M. Morgan is on the source record.
What is the OpenAlex record for Todd M. Morgan?
ScholarIQopenalex
The OpenAlex for Todd M. Morgan is on the source record.
What are the most-cited papers on Todd M. Morgan?
ScholarIQmost cited works
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology
Edward M. Schaeffer, Sandy Srinivas, Nabil Adra, Yi An, Daniel A. Barocas, Rhonda L. Bitting, Alan H. Bryce, Brian F. Chapin, Heather H. Cheng, Anthony V. D’Amico, Neil Desai, Tanya B. Dorff, James A. Eastham, Thomas A. Farrington, Xin Gao, Shilpa Gupta, Thomas Guzzo, Joseph E. Ippolito, Michael Kuettel, Joshua M. Lang, Tamara L. Lotan, Rana R. McKay, Todd M. Morgan, George J. Netto, Julio M. Pow‐Sang, Robert E. Reiter, Mack Roach, Tyler P. Robin, Stan Rosenfeld, Ahmad Shabsigh, Daniel E. Spratt, Benjamin A. Teply, Jonathan D. Tward, Richard K. Valicenti, J.K. Wong, Dorothy A. Shead, Jenna Snedeker, Deborah A. Freedman-Cass
Association of Black Race With Prostate Cancer–Specific and Other-Cause Mortality
Robert T. Dess, Holly Hartman, Brandon A. Mahal, Payal Soni, Will Jackson, Matthew R. Cooperberg, Christopher L. Amling, William J. Aronson, Christopher J. Kane, Martha K. Terris, Zachary S. Zumsteg, Santino Butler, Joseph R. Osborne, Todd M. Morgan, Rohit Mehra, Simpa S. Salami, Amar U. Kishan, Chenyang Wang, Edward M. Schaeffer, Mack Roach, Thomas M. Pisansky, William U. Shipley, Stephen J. Freedland, Howard M. Sandler, Susan Halabi, Felix Y. Feng, James J. Dignam, Paul L. Nguyen, Matthew J. Schipper, Daniel E. Spratt
Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
Homayoun Zargar, Patrick Espiritu, Adrian Fairey, Laura S. Mertens, Colin P. Dinney, Maria Carmen Mir, Laura-Maria Krabbe, Michael S. Cookson, Niels-Erik Jacobsen, Nilay Gandhi, Joshua Griffin, Jeffrey S. Montgomery, Nikhil Vasdev, Evan Y. Yu, David Youssef, Évanguelos Xylinas, Nicholas Campain, Wassim Kassouf, Marc Dall’Era, Jo-An Seah, Cesar E. Ercole, Simon Horenblas, Srikala S. Sridhar, John McGrath, Jonathan Aning, Shahrokh F. Shariat, Jonathan L. Wright, Andrew C. Thorpe, Todd M. Morgan, Jeff M. Holzbeierlein, Trinity J. Bivalacqua, Scott North, Daniel A. Barocas, Yair Lotan, Jorge A. García, Andrew J. Stephenson, Jay B. Shah, Bas W. van Rhijn, Siamak Daneshmand, Philippe E. Spiess, Peter C. Black
Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials
Andre Esteva, Jean Feng, Douwe van der Wal, Shih-Cheng Huang, Jeffry Simko, Sandy DeVries, Emmalyn Chen, Edward M. Schaeffer, Todd M. Morgan, Yilun Sun, Amirata Ghorbani, Nikhil Naik, Dhruv Nathawani, Richard Socher, Jeff M. Michalski, Mack Roach, Thomas M. Pisansky, Jedidiah M. Monson, Farah Naz, James A. Wallace, Michelle Ferguson, Jean-Paul Bahary, James Zou, Matthew P. Lungren, Serena Yeung, Ashley E. Ross, Michael Jonathan Kucharczyk, Luís Souhami, Leslie Ballas, Christopher A. Peters, Sandy Liu, Alexander G. Balogh, Pamela Randolph-Jackson, David L. Schwartz, M.R. Girvigian, Naoyuki G. Saito, Adam Raben, Rachel Rabinovitch, Khalil Katato, Howard M. Sandler, Phuoc T. Tran, Daniel E. Spratt, Stephanie L. Pugh, Felix Y. Feng, Osama Mohamad